Cargando…

Caveats of bisphosphonate abuse

BACKGROUND: Bisphosphonates (BPs) are the common drugs used for the treatment of postmenopausal osteoporosis. Short term benefits of the BPs are well known. However, there are concerns regarding their long term use. The aim of the study was to analyze the association between atypical femoral fractur...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwala, Sanjay, Agashe, Vikas M, Shetty, Vivek, Mohrir, Ganesh, Moonot, Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964778/
https://www.ncbi.nlm.nih.gov/pubmed/27512227
http://dx.doi.org/10.4103/0019-5413.185612
_version_ 1782445165265289216
author Agarwala, Sanjay
Agashe, Vikas M
Shetty, Vivek
Mohrir, Ganesh
Moonot, Pradeep
author_facet Agarwala, Sanjay
Agashe, Vikas M
Shetty, Vivek
Mohrir, Ganesh
Moonot, Pradeep
author_sort Agarwala, Sanjay
collection PubMed
description BACKGROUND: Bisphosphonates (BPs) are the common drugs used for the treatment of postmenopausal osteoporosis. Short term benefits of the BPs are well known. However, there are concerns regarding their long term use. The aim of the study was to analyze the association between atypical femoral fractures and BP misuse/abuse as well as study the outcome of management of these fractures. MATERIALS AND METHODS: A retrospective study of a prospectively studied patients who presented with atypical femoral fractures between January 2010 and August 2012 and were followed up upto June 2014. The cohort consisted of nine female patients (12 fractures) with an average age of 71 years (range 58-85 years). Analysis was done for the indications, duration of BP use, configuration of associated fractures and method of treatment. RESULTS: The mean duration of BP use was 6.6 years (range 4-10 years). BP treatment was initiated without sufficient indication and continued without proper review and followup in most cases. Most patients did not followup and continued to consume BPs without any review by the doctors. All patients had prodromal thigh pain of various duration, which was inadequately investigated and managed before the presentation. Two cases with an incomplete fracture and no thigh pain were managed successfully with conservative treatment. The rest were treated by surgery with intramedullary nailing. The average union time was longer and two fractures went into nonunion which required further surgical intervention. CONCLUSION: Atypical femoral fractures appear to be strongly related to abuse of BPs. Great care is to be exercised at initiation as well as the continuation of BP therapy, and regular review is required. There is a need for improved awareness among physicians about the possibility of such fractures, and interpretation of thigh pain and radiological findings, especially if the patient has been on BPs therapy. Internal fixation for complete fractures and for incomplete fractures with thigh pain is needed. Delayed union is common.
format Online
Article
Text
id pubmed-4964778
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49647782016-08-10 Caveats of bisphosphonate abuse Agarwala, Sanjay Agashe, Vikas M Shetty, Vivek Mohrir, Ganesh Moonot, Pradeep Indian J Orthop Original Article BACKGROUND: Bisphosphonates (BPs) are the common drugs used for the treatment of postmenopausal osteoporosis. Short term benefits of the BPs are well known. However, there are concerns regarding their long term use. The aim of the study was to analyze the association between atypical femoral fractures and BP misuse/abuse as well as study the outcome of management of these fractures. MATERIALS AND METHODS: A retrospective study of a prospectively studied patients who presented with atypical femoral fractures between January 2010 and August 2012 and were followed up upto June 2014. The cohort consisted of nine female patients (12 fractures) with an average age of 71 years (range 58-85 years). Analysis was done for the indications, duration of BP use, configuration of associated fractures and method of treatment. RESULTS: The mean duration of BP use was 6.6 years (range 4-10 years). BP treatment was initiated without sufficient indication and continued without proper review and followup in most cases. Most patients did not followup and continued to consume BPs without any review by the doctors. All patients had prodromal thigh pain of various duration, which was inadequately investigated and managed before the presentation. Two cases with an incomplete fracture and no thigh pain were managed successfully with conservative treatment. The rest were treated by surgery with intramedullary nailing. The average union time was longer and two fractures went into nonunion which required further surgical intervention. CONCLUSION: Atypical femoral fractures appear to be strongly related to abuse of BPs. Great care is to be exercised at initiation as well as the continuation of BP therapy, and regular review is required. There is a need for improved awareness among physicians about the possibility of such fractures, and interpretation of thigh pain and radiological findings, especially if the patient has been on BPs therapy. Internal fixation for complete fractures and for incomplete fractures with thigh pain is needed. Delayed union is common. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4964778/ /pubmed/27512227 http://dx.doi.org/10.4103/0019-5413.185612 Text en Copyright: © Indian Journal of Orthopaedics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Agarwala, Sanjay
Agashe, Vikas M
Shetty, Vivek
Mohrir, Ganesh
Moonot, Pradeep
Caveats of bisphosphonate abuse
title Caveats of bisphosphonate abuse
title_full Caveats of bisphosphonate abuse
title_fullStr Caveats of bisphosphonate abuse
title_full_unstemmed Caveats of bisphosphonate abuse
title_short Caveats of bisphosphonate abuse
title_sort caveats of bisphosphonate abuse
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964778/
https://www.ncbi.nlm.nih.gov/pubmed/27512227
http://dx.doi.org/10.4103/0019-5413.185612
work_keys_str_mv AT agarwalasanjay caveatsofbisphosphonateabuse
AT agashevikasm caveatsofbisphosphonateabuse
AT shettyvivek caveatsofbisphosphonateabuse
AT mohrirganesh caveatsofbisphosphonateabuse
AT moonotpradeep caveatsofbisphosphonateabuse